These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11168975)

  • 1. Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease.
    Kielstein JT; Bode-Böger SM; Frölich JC; Haller H; Böger RH
    Kidney Int Suppl; 2001 Feb; 78():S9-13. PubMed ID: 11168975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
    Kielstein JT; Böger RH; Bode-Böger SM; Schäffer J; Barbey M; Koch KM; Frölich JC
    J Am Soc Nephrol; 1999 Mar; 10(3):594-600. PubMed ID: 10073610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A; Zhao Y; Warren JS
    Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.
    Fliser D
    Eur J Clin Invest; 2005 Feb; 35(2):71-9. PubMed ID: 15667575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
    Aldámiz-Echevarría L; Andrade F
    Int J Mol Sci; 2012; 13(9):11288-11311. PubMed ID: 23109853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
    Böger RH
    J Nutr; 2004 Oct; 134(10 Suppl):2842S-2847S; discussion 2853S. PubMed ID: 15465797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.
    Uzun H; Konukoglu D; Besler M; Erdenen F; Sezgin C; Muderrisoglu C
    Clin Invest Med; 2008; 31(1):E1-7. PubMed ID: 18312743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
    Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine, arginine analogs and nitric oxide production in chronic kidney disease.
    Baylis C
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):209-20. PubMed ID: 16932427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
    Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase.
    Scalera F; Kielstein JT; Martens-Lobenhoffer J; Postel SC; Täger M; Bode-Böger SM
    J Am Soc Nephrol; 2005 Apr; 16(4):892-8. PubMed ID: 15728783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
    Kielstein JT; Zoccali C
    Am J Kidney Dis; 2005 Aug; 46(2):186-202. PubMed ID: 16112037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC; Stanger O
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.
    Ito A; Tsao PS; Adimoolam S; Kimoto M; Ogawa T; Cooke JP
    Circulation; 1999 Jun; 99(24):3092-5. PubMed ID: 10377069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differences of asymmetric dimethylarginine removal by different dialysis treatments.
    Zhang DL; Liu J; Liu S; Zhang Y; Liu WH
    Ren Fail; 2010; 32(8):935-40. PubMed ID: 20722560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease.
    Böger RH; Zoccali C
    Atheroscler Suppl; 2003 Dec; 4(4):23-8. PubMed ID: 14664899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.